Discover Pancreatic Cancer Demystified: Expert Insights and Breakthroughs with Robert H. Vonderheide – Cancer Research Institute
Cancer Research Institute (CRI) shared on their LinkedIn:
”Register to discover Pancreatic Cancer Demystified: Expert Insights and Breakthroughs with Robert H. Vonderheide!
Pancreatic cancer, often termed ‘the silent killer,’ is a relentless and merciless adversary. Ranking as the world’s most lethal form of cancer, it is currently the fourth leading cause of cancer-related deaths in United States.
Why is pancreatic cancer so difficult to diagnose? What treatment options are available against such a deadly foe? Join us on June 26 for an exclusive, live webinar featuring renowned cancer immunologist, CRI Scientific Advisory Council member, and Clinical Accelerator Investigator, Robert H. Vonderheide from the Abramson Cancer Center of the University of Pennsylvania.
Dr. Vonderheide will delve into these pressing questions and provide a deeper dive into the latest advances in immunotherapy for pancreatic cancer patients. This is a unique opportunity to gain invaluable insights from one of the leading experts in the field.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023